NCT07375797Active, not recruiting
Fecal Microbiota Transplantation Intervention on Microbiota Composition and Insulin Sensitivity in Diabetes
Source: ClinicalTrials.gov · Last updated 14 Jul 2026
Brief summary (registry, in English)
The purpose of the trial is to investigate the effect of fecal microbiota transplantation versus placebo on glycemic metabolism and gut microbiota composition in people with type 2 diabetes.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 16 (estimated)
- First submitted
- 12 Jan 2026
- Start date
- 5 Feb 2026
- Primary completion date
- 25 Jun 2026
- Lead sponsor
- Central Jutland Regional Hospital
- Diseases
- Type 2 diabetes
- NCT number
- NCT07375797
What you commit to
- Study type: Interventional
- Planned participants: 16
- From 5 Feb 2026 to the primary completion date, 25 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Treatment with insulin or sulfonylurea drugs.
- Treatment with antibiotics, probiotics/lactic acids cultures, or proton pump inhibitors within the last three months.
- Bariatric surgery within the previous year or a plan to undergo bariatric surgery during the study period
- Self-reported drug or alcohol abuse
Other illness
- Diagnosed with unstable angina, recent (within the last 8 weeks) myocardial infarction, any disease in the coronal arteries, decompensated heart failure (NYHA II-IV), severe valvular disease, lung disease
- Hypertension which is not currently under medical control (systolic pressure \>200 mmHg and/or diastolic pressure \>130 mmHg)
- Disease of the liver and/or gallbladder, including parenchymal liver disease, liver cirrhosis, pancreatitis, autoimmune liver disease
- All diseases of the gastrointestinal tract, which can lead to or increase the risk of defects in the mucosal membrane. This includes chronic diarrhea, inflammatory bowel disease, malabsorption, malnutrition, recent infection with clostridium difficile, primary sclerosing cholangitis, radiation induced enteritis, chemotherapy induced diarrhea, hematological diseases
- Anemia and other diseases of the bone marrow
- Kidney diseases, including moderate albuminuria and other disturbances in the electrolytes balance
- Food allergies, allergies towards catheters (i.e. Venflon) and other instruments used in the study.
- Other condition deeming individuals inappropriate for recruitment according to the investigators or sponsor
Other
- Regular exercise and/or more than 150 minutes of moderate intensity exercise or 75 minutes of high intensity exercise per week, within the last 6 months.
- Patients preparing for or currently experiencing pregnancy during the study period
- Reactive hypoglycemia
Who the study is looking for
- Has type 2 diabetes
Age in the registry: 18 years to 67 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Medical Diagnostics Center, Regional Hospital Central Jutland (HEM) Coordinator of this site? Confirm its status | Viborg | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.